drugset / Trial / NCT02341378

Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis

NCT02341378 ↗

Phase 2 Completed 28 enrolled Kolon Life Science
RandomizedParallel-groupSingle-blindTreatment

Summary

To assess the efficacy and safety of the intra-articular injection of TissueGene-C in patients with degenerative arthritis of the knee

Timeline

Start
2009-08
Primary completion
2010-06
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject TissueGene-C Cell therapy 6e+06 cells Other
Subject TissueGene-C Cell therapy 1.8e+07 cells Other

Indications